MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+20.77%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$204M
AUM Growth
+$204M
(+9%)
Cap. Flow
-$580K
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$580K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Entrada Therapeutics
TRDA
$208M
| $66.8M | 32.82% | 4,425,784 | – | – |
|
2
Dyne Therapeutics
DYN
$1.92B
| $65.9M | 32.36% | 4,951,303 | – | – |
|
3
iTeos Therapeutics
ITOS
| $30M | 14.74% | 2,738,785 | – | – |
|
4
Werewolf Therapeutics
HOWL
$59.9M
| $16.5M | 8.13% | 4,284,172 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $16.4M | 8.04% | 2,242,636 | – | – |
|
|
ADAP
6
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.41M | 2.16% | 5,555,461 -731,640 | -12% | -$580K |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.56M | 1.75% | 313,136 | – | – |
|